A double-blind, placebo-controlled, randomized, dose-escalating study of single and multiple oral doses of finafloxacin hydrochloride in healthy subjects and a study of H [Helicobacter] pylori treatment in healthy carriers

Trial Profile

A double-blind, placebo-controlled, randomized, dose-escalating study of single and multiple oral doses of finafloxacin hydrochloride in healthy subjects and a study of H [Helicobacter] pylori treatment in healthy carriers

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Jan 2018

At a glance

  • Drugs Finafloxacin (Primary)
  • Indications Helicobacter pylori infections
  • Focus Adverse reactions
  • Most Recent Events

    • 16 Jan 2018 Results (n=266) of pooled data from three trial assessing population pharmacokinetics of finafloxacin in healthy volunteers and patients with complicated urinary tract infections, were published in the Antimicrobial Agents and Chemotherapy.
    • 03 Dec 2008 Actual patient number added.
    • 03 Dec 2008 Results were presented at ICAAC 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top